CS MEDICA A/S: CS MEDICA announces that their CANNANSEN®CBD Anti-Hair Loss serum has been successfully approved in the United Arab Emirates
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that their CANNANSEN®CBD Anti-Hair Loss serum has been successfully approved in the United Arab Emirates. The CANNANSEN®CBD Anti-Hair Loss serum has been through an approval procedure at the United Arab Emirates Health Authorities.The approval of the CANNANSEN®CBD Anti-Hair Loss serum from the United Arab Emirates Health Authorities is of importance for the Company’s efforts to gain brand awareness globally. The approval enables CS MEDICA to market and sell the CANNANSEN®CBD Anti-Hair Loss serum in the United Arab Emirates. The